Company profile
Modalis Therapeutics
Modalis is an emerging biotech company that develops therapeutics using CRISPR based technology
- Industry
- Biotechnology Research
- Employees
- 23
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2016
- LinkedIn followers
- 4,558
- Office locations
- 2
Modalis Therapeutics company summary
Modalis Therapeutics is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2016. On LinkedIn the company has around 23 employees and 4,558 followers. The company lists 2 office locations.
What technology does Modalis Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Modalis Therapeutics
Modalis Therapeutics Corporation (Tokyo Mothers 4883) is developing precision genetic medicines through epigenetic gene modulation. Modalis is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology which enables the locus specific modulation of gene expression or histone modification without the need for double- stranded DNA cleavage, gene editing or base editing. Modalis is headquartered in Tokyo with laboratories and R&D facilities in Cambridge,
Where is Modalis Therapeutics located?
Modalis Therapeutics lists 2 office locations.
Compare companies similar to Modalis Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Modalis Therapeutics modalistx.com | Biotechnology Research | 23 | 2016 | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Modalis Therapeutics
What does Modalis Therapeutics do?
Modalis Therapeutics Corporation (Tokyo Mothers 4883) is developing precision genetic medicines through epigenetic gene modulation. Modalis is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology which enables the locus specific modulation of gene expression or histone modification without the need for double- stranded DNA cleavage, gene editing or base editing. Modalis is headquartered in Tokyo with laboratories and R&D facilities in Cambridge,
How many employees does Modalis Therapeutics have?
Modalis Therapeutics has around 23 employees on LinkedIn.
Where is Modalis Therapeutics headquartered?
Modalis Therapeutics is headquartered in Cambridge, Massachusetts.
Where does Modalis Therapeutics have offices?
Modalis Therapeutics lists 2 office locations, including Cambridge, Massachusetts, US; Chuou-ku, Tokyo 104-0032, JP.
When was Modalis Therapeutics founded?
Modalis Therapeutics was founded in 2016.
Build a lead list from companies like Modalis Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.